EP3690425B1 - Measurement device and measurement method for hematoctrit - Google Patents
Measurement device and measurement method for hematoctrit Download PDFInfo
- Publication number
- EP3690425B1 EP3690425B1 EP17927545.8A EP17927545A EP3690425B1 EP 3690425 B1 EP3690425 B1 EP 3690425B1 EP 17927545 A EP17927545 A EP 17927545A EP 3690425 B1 EP3690425 B1 EP 3690425B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- light
- irradiator
- component
- blood
- scattered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000005259 measurement Methods 0.000 title description 6
- 238000000691 measurement method Methods 0.000 title 1
- 210000004369 blood Anatomy 0.000 claims description 38
- 239000008280 blood Substances 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 29
- 238000005534 hematocrit Methods 0.000 claims description 20
- 230000003287 optical effect Effects 0.000 claims description 12
- 230000017531 blood circulation Effects 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 5
- 239000012530 fluid Substances 0.000 description 37
- 210000002381 plasma Anatomy 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
- G01N21/53—Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke
- G01N21/532—Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke with measurement of scattering and transmission
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4707—Forward scatter; Low angle scatter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4709—Backscatter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4711—Multiangle measurement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4726—Detecting scatter at 90°
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
- G01N2021/4764—Special kinds of physical applications
- G01N2021/4769—Fluid samples, e.g. slurries, granulates; Compressible powdery of fibrous samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/061—Sources
- G01N2201/06113—Coherent sources; lasers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Definitions
- FIG. 7 is a plan view illustrating a configuration of the measuring apparatus according to the second practical example.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
- The present invention relates to a measuring apparatus and a measuring method that can measure information about a fluid.
- For this type of apparatus, there is known an apparatus configured to irradiate fluid with light and to receive scattered light, thereby measuring information about the fluid. In the fluid, irradiation light is scattered in a plurality of directions. If those scattered lights are separately detected, it is considered that the information about the fluid can be measured by using respective properties of the scattered lights (e.g., refer to Patent Literature 1).
Patent Literature 2 describes a measuring device for determining hemolysis. The measuring device comprises a transmitter and a receiver arranged opposite of each other and on both sides of a hose line on a common axis. For the detection of scattered radiation, the measuring device contains three further receivers. The Lambert-Beer law describes the relationship between the intensity of the incident light and the emitted light to calculate the hematocrit value in the control and analysis unit. This document discloses the preamble of claim 1. - Patent Literature 3 describes a device for measuring a blood constituent in blood for an extracorporeal blood treatment device, comprising a dialyzer or a filter, and a hose line system comprising hose lines that are pervious to electromagnetic radiation.
-
- Patent Literature 1:
Japanese Patent No. 4451567 - Patent Literature 2:
JP 2016 540971 A - Patent Literature 3:
US 2012/031841 A1 - The scattered light may include not only forward scattered light and backscattered light, but also side scattered light (i.e., light scattered in a direction substantially perpendicular to an optical axis in a surface layer of the fluid). A method of measuring the information about the fluid by using the side scattered light, however, still has room for improvement. For example, in a technology/technique described in the Patent Literature 1, a change in components of the fluid may also change a relation among scatter components. Thus, in the measurement of fluids having different components, measurement precision is significantly reduced, which is technically problematic.
- The above is an example of problems to be solved by the present invention. It is therefore an object of the present invention to provide a measuring apparatus and a measuring method that can measure the information about the fluid by using the side scattered light.
- The invention is defined by the apparatus of appended claim 1 and the method of appended claim 6.
-
- [
FIG. 1] FIG. 1 is a plan view illustrating a configuration of a measuring apparatus according to a first practical example. - [
FIG. 2] FIG. 2 is version 1 of a cross sectional view illustrating a plurality of scatter components of irradiation light and a placement location of each light receiver. - [
FIG. 3] FIG. 3 isversion 2 of a cross sectional view illustrating a plurality of scatter components of irradiation light and a placement location of each light receiver. - [
FIG. 4] FIG. 4 is a graph illustrating a relation between a transmitted light amount and a side scattered light amount. - [
FIG. 5] FIG. 5 is a graph illustrating a relation between the transmitted light amount and a backscattered light amount. - [
FIG. 6] FIG. 6 is a graph illustrating a relation between the transmitted light amount and a sum of the side scattered light amount and the backscattered light amount. - [
FIG. 7] FIG. 7 is a plan view illustrating a configuration of a measuring apparatus according to a second practical example. - <1> A measuring apparatus according to the invention is provided with:
an irradiator configured to irradiate fluid with light; a first light receiver configured to receive a forward scatter component of scattered light scattered by the fluid; a second light receiver configured to receive a backscatter component of the scattered light; a third light receiver configured to receive a side scatter component of the scattered light; and an outputting device configured to output fluid information about the fluid, which is obtained on the basis of light receiving signals of the first light receiver, the second light receiver, and the third light receiver. - According to the measuring apparatus in the invention, in operation thereof, for example, the fluid that flows in a tubing is irradiated with light by the irradiator. The light irradiated or applied from the irradiator is scattered in the fluid and becomes the scattered light.
- The scattered light is received by each of the plurality of receivers arranged in different positions. Specifically, the forward scatter component of the scattered light is received by the first light receiver, the backscatter component of the scattered light is received by the second light receiver, and the side scatter component of the scattered light is received by the third light receiver. From the light receiving signals of the first light receiver, the second light receiver, and the third light receiver, the fluid information about the fluid is obtained, and is outputted from the outputting device.
- In the invention, as described above, at least three scatter components (i.e., the forward scatter component, the backscatter component, and the side scatter component) are used to obtain the fluid information. It is thus possible to output accurate fluid information, in comparison with that when the fluid information is obtained on the basis of only one or two scatter components.
- Moreover, the fluid in the invention is blood, but the measurement, outside the scope of the present invention, can be also applied to any fluid other than the blood (e.g., ink, oil, wastewater or sewage, a seasoning, etc.).
- Furthermore, the fluid information in the invention is a ratio of the volume of blood cells or blood corpuscles in the blood (which is a so-called hematocrit value).
- <2> In the invention, the outputting device is configured to output the fluid information, which is obtained on the basis of a sum of the backscatter component and the side scatter component, and on the basis of the forward scatter component.
- According to studies by the present inventors, it is found that there is a fixed relation between the sum of the backscatter component and the side scatter component, and the forward scatter component. It is thus possible to output the accurate fluid information, more easily, by using the sum of the backscatter component and the side scatter component, and by using the forward scatter component.
- <3> In another aspect of the measuring apparatus according to the invention, the irradiator is placed such that an optical axis of irradiation light is diagonal to a direction in which the fluid flows.
- According to this aspect, since oblique light is applied with respect to the direction in which the fluid flows, it is easy to place the third light receiver configured to receive the side scatter component. It is also easy to detect a Doppler signal.
- <4> In the aforementioned aspect in which the irradiator is placed such that the optical axis is diagonal, the irradiator may be placed such that the optical axis of the irradiation light is at an angle other than a vicinity of 45 degrees to the direction in which the fluid flows.
- If the light is irradiated or applied at an angle of the vicinity of 45 degrees to the direction in which the fluid flows, strong scattered light, which includes the backscatter component, enters the third light receiver configured to receive the side scattered light, and it is hardly possible to appropriately receive the side scatter component. If the light is irradiated or applied at the angle other than the vicinity of 45 degrees, the aforementioned detrimental effect can be avoided.
- <5> In another aspect of the measuring apparatus according to the invention, the irradiator includes a first irradiator and a second irradiator, the first light receiver is configured to receive a forward scatter component of scattered light of the first irradiator; the second light receiver is configured to receive a backscatter component of the scattered light of the first irradiator; and the third light receiver is configured to receive a side scatter component of scattered light of the second irradiator.
- According to this aspect, the first irradiator for generating the forward scatter component and the backscatter component and the second irradiator for generating the side scatter component are provided, separately. Thus, in comparison with a single irradiator, it is possible to make measurements in the conditions that are suitable for the respective scatter components.
<6> - <7> A measuring method according to the invention is a measuring method provided with: an irradiating process of irradiating fluid with light; a first light receiving process of receiving a forward scatter component of scattered light scattered by the fluid; a second light receiving process of receiving a backscatter component of the scattered light; a third light receiving process of receiving a side scatter component of the scattered light; and an outputting process of outputting fluid information about the fluid, which is obtained on the basis of light receiving signals of the first light receiving process, the second light receiving process, and the third light receiving process.
- According to the measuring method in the invention, as in the measuring apparatus described above, at least three scatter components are used to obtain the fluid information. It is thus possible to output the accurate fluid information, in comparison with that when the fluid information is obtained on the basis of only one or two scatter components.
- <8> The effect and other benefits of the measuring apparatus, the measuring method according to the invention will be explained in more detail in practical examples below.
- Hereinafter, a measuring apparatus according to practical examples will be explained in detail with reference to the drawings. In the following, an explanation will be given to a situation in which the measuring apparatus is applied to an apparatus for measuring the concentration (or a hematocrit value) of blood that flows in a tubing that constitutes a blood circuit of an artificial dialysis apparatus.
- Firstly, a configuration of the measuring apparatus according to a first practical example will be explained with reference to
FIG. 1. FIG. 1 is a plan view illustrating the configuration of the measuring apparatus according to the first practical example. - As illustrated in
FIG. 1 , the measuring apparatus according to the first practical example is configured as an apparatus for measuring a hematocrit value of blood by irradiating the blood that flows in atubing 300, with light. The measuring apparatus is provided with anirradiator 100, afirst light receiver 210, a secondlight receiver 220, a thirdlight receiver 230, and ablood information processor 400. - The
irradiator 100 is configured, for example, as a laser light source, and is configured to irradiate the blood that flows in thetubing 300, with light. Theirradiator 100 is placed such that an optical axis of irradiation light is an angle of θ1 to a direction in which the blood flows (i.e., a flow axis inFIG. 1 ). θ1 may be an angle other than the vicinity of 90 degrees and the vicinity of 45 degrees. The reason of avoiding setting θ1 in the vicinity of 90 degrees is to facilitate the placement of the thirdlight receiver 230 described later. The reason of avoiding setting θ1 in the vicinity of 45 degrees is to prevent strong scattered light, which includes a backscatter component, from entering the thirdlight receiver 230 described later. - The
first light receiver 210 is placed in a position in which it can receive a component that passes through the blood (i.e., a forward scatter component), out of light scattered by the blood that flows in thetubing 300. Specifically, thefirst light receiver 210 is placed in a position opposite to theirradiator 100, as viewed from thetubing 300. Thefirst light receiver 210 is configured to output a signal corresponding to the received forward scatter component, to theblood information processor 400. - The second
light receiver 220 is placed in a position in which it can receive a component that is scattered in a direction of the position of the irradiator 100 (i.e., a backscatter component), out of the light scattered by the blood that flows in thetubing 300. Specifically, the secondlight receiver 220 is placed in a position extremely close to theirradiator 100. The secondlight receiver 220 is configured to output a signal corresponding to the received backscatter component, to theblood information processor 400. - The third
light receiver 230 is placed in a position in which it can receive a component that is scattered in a direction that is different from the direction of the position of the irradiator 100 (i.e., a side scatter component), out of the light scattered by the blood that flows in thetubing 300. Specifically, the thirdlight receiver 230 is placed in a direction at an angle of θ2 to the optical axis of irradiation light. θ2 is in the vicinity of 90 degrees. - The
blood information processor 400 is configured to arithmetically operate and output blood information (which is herein the hematocrit value of the blood), on the basis of the light receiving signals inputted from thefirst light receiver 210, the secondlight receiver 220, and the thirdlight receiver 230. A method of arithmetically operating the blood information will be detailed later. - For convenience of explanation, in
FIG. 1 , a positional relation of the light receivers is illustrated, two-dimensionally, but the light receivers may be arranged, three-dimensionally. Hereinafter, a three-dimensional arrangement of thefirst light receiver 210, the secondlight receiver 220, and the thirdlight receiver 230 will be explained with reference toFIG. 2 andFIG. 3 .FIG. 2 is version 1 of a cross sectional view illustrating a plurality of scatter components of the irradiation light and a placement location of each light receiver.FIG. 3 isversion 2 of a cross sectional view illustrating a plurality of scatter components of irradiation light and a placement location of each light receiver. - Each of coordinate axes in
FIG. 2 andFIG. 3 corresponds to a coordinate axis inFIG. 1 . In other words,FIG. 2 is a cross sectional view in a direction in which the blood flows from a left side to a right side in the drawing.FIG. 3 is a cross sectional view in a direction in which the blood flows from a far side to a near side in the drawing. - As illustrated in
FIG. 2 andFIG. 3 , each of various components of the scattered light (i.e., the forward scatter component, the backscatter component, and the side scatter component) spreads from a scattering point (which is specifically a surface layer of the blood), three-dimensionally and radially. Thus, even when thefirst light receiver 210, the secondlight receiver 220, and the thirdlight receiver 230 are arranged, three-dimensionally, as illustrated inFIG. 2 andFIG. 3 , the light receivers can receive the respective scatter components. This three-dimensional arrangement increases the degree of freedom of an arrangement layout of the light receivers. - Next, a relation among the scatter components and a resulting problem thereof will be explained with reference to
FIG. 4 andFIG. 5 .FIG. 4 is a graph illustrating a relation between a transmitted light amount and a side scattered light amount.FIG. 5 is a graph illustrating a relation between the transmitted light amount and a backscattered light amount. - As illustrated in
FIG. 4 , a relation between an amount of light received by the first light receiver 210 (hereinafter referred to a "transmitted light amount" as occasion demands) and an amount of light received by the third light receiver 230 (hereinafter referred to a "side scattered light amount" as occasion demands) changes between when protein concentration in blood plasma in the blood is high and when it is low. Specifically, when the protein concentration in the blood plasma changes, a relation between a logarithm of the transmitted light amount (Log transmitted light amount) and the side scattered light amount linearly changes. At this time, a slope of a straight line varies depending on the type of the blood. As is clear from the drawing, a slope of a straight line of the blood A is clearly different from that of the blood B. - As illustrated in
FIG. 5 , a relation between the amount of the light received by the first light receiver 210 (i.e., the transmitted light amount) and an amount of light received by the second light receiver 220 (hereinafter referred to a "backscattered light amount" as occasion demands) also changes between when the protein concentration in the blood plasma in the blood is high and when it is low. Specifically, when the protein concentration in the blood plasma changes, a relation between the logarithm of the transmitted light amount (Log transmitted light amount) and the backscattered light amount linearly changes. At this time, a slope of a straight line varies depending on the type of the blood. As is clear from the drawing, a slope of a straight line of the blood A is clearly different from that of the blood B. - The results in
FIG. 4 andFIG. 5 may mean that the hematocrit value cannot be accurately measured from the transmitted light amount and the side scattered light amount, or from the transmitted light amount and the backscattered light amount. In order to solve the problem, the measuring apparatus according to the first practical example is configured to calculate the hematocrit value by using the three types of scatter components. - Next, a method of deriving the hematocrit value by the measuring apparatus according to the first practical example will be explained with reference to
FIG. 6. FIG. 6 is a graph illustrating a relation between the transmitted light amount and a sum of the side scattered light amount and the backscattered light amount (or an average value of the side scattered light amount and the backscattered light amount). - As illustrated in
FIG. 6 , according to studies by the present inventors, it is found that there is a fixed relation between the transmitted light amount and the sum of the side scattered light amount and the backscattered light amount. Specifically, when the transmitted light amount is L1, the side scattered light amount is L2, and the backscattered light amount, the following relation is established. - As a result, by measuring each of the transmitted light amount, the side scattered light amount, and the backscattered light amount, the hematocrit value can be arithmetically operated by using the above relation. The hematocrit value may be arithmetically operated by using a predetermined mathematical expression, or may be determined by preparing a map as illustrated in
FIG. 6 in advance. - For example, when the transmitted light amount (i.e., LogL1) is A, if the sum of the side scattered light amount and the backscattered light amount (i.e., (α×L2+β×L3)/2) is a, then, the hematocrit value can be determined to be Hct=50. When the transmitted light amount (i.e., LogL1) is A, if the sum of the side scattered light amount and the backscattered light amount (i.e., (α×L2+β×L3)/2) is b, then, the hematocrit value can be determined to be Hct=40.
- As explained above, according to the measuring apparatus in the first practical example, it is possible to arithmetically operate an accurate hematocrit value, by measuring each of the transmitted light amount (i.e., the forward scatter component of the scattered light), the side scattered light amount (i.e., the side scatter component of the scattered light), and the backscattered light amount (i.e., the backscatter component of the scattered light).
- Next, a measuring apparatus according to a second practical example will be explained with reference to
FIG. 7. FIG. 7 is a plan view illustrating a configuration of the measuring apparatus according to the second practical example. - The second practical example is partially different in configuration from the first practical example described above, and is substantially the same in other part. Thus, hereinafter, only a different part from the first practical example will be explained in detail, and an explanation of the same part will be omitted, as occasion demands.
- As illustrated in
FIG. 7 , the measuring apparatus according to the second practical example is provided with two irradiators (which are specifically afirst irradiator 110 and a second irradiator 120). - The
first irradiator 110 is configured to apply light for measuring the transmitted light amount and the backscattered light amount. Thus, thefirst light receiver 210, which is configured to receive the forward scatter component, is placed opposite to thefirst irradiator 110, as viewed from thetubing 300, and the secondlight receiver 220, which is configured to receive the backscatter component, is placed extremely close to thefirst irradiator 110. - The
second irradiator 120 is configured to apply light for measuring the side scattered light amount. Thus, thesecond irradiator 120 is placed such that an optical axis of irradiation light is an angle of θ1 to a direction in which the blood flows (i.e., a flow axis). Moreover, the thirdlight receiver 230 is placed in a direction at an angle of θ2 to the optical axis of the light applied by thesecond irradiator 120. - According to the measuring apparatus in the second practical example, the provision of the two irradiators makes it possible to realize measurement conditions corresponding to the respective scatter components. Specifically, by placing the
first irradiator 110 such that the light applied by thefirst irradiator 110 enters substantially perpendicular to the flow axis while diagonally setting the optical axis of thesecond irradiator 120 for measuring the side scattered light amount, it is possible to narrow a scattering range of the transmitted light, in comparison with that when the optical axis of thefirst irradiator 110 is diagonally set, so that it is possible to miniaturize thefirst irradiator 110. - The present invention is not limited to the aforementioned embodiments and examples, but various changes may be made, if desired, without departing from the scope of the invention as defined by the appended claims.
-
- 100
- irradiator
- 110
- first irradiator
- 120
- second irradiator
- 210
- first light receiver
- 220
- second light receiver
- 230
- third light receiver
- 300
- tubing
- 400
- blood information processor
Claims (6)
- A measuring apparatus comprising:an irradiator (100) configured to irradiate blood with light;a first light receiver (210) configured to receive a forward scatter component of scattered light scattered by the blood;a second light receiver (220) configured to receive a backscatter component of the scattered light;a third light receiver (230) configured to receive a side scatter component of the scattered light; andan outputting device (400) configured to output hematocrit value of the blood, characterised in that:the hematocrit value
is obtained on the basis of light receiving signals of said first light receiver (210), said second light receiver (220), and said third light receiver (230),wherein said outputting device (400) is configured to determine the hematocrit value using a relationship between the sum of the backscatter component and the side scatter component, and the forward scatter component. - The measuring apparatus according to claim 1, wherein said outputting device (400) is configured to determine the hematocrit value using the proportional relationship between the sum of the backscatter component and side scatter component, and the logarithm of the forward scatter component.
- The measuring apparatus according to claim 1 or 2, wherein said irradiator (100) is placed such that an optical axis of irradiation light is diagonal to a direction in which the blood flows.
- The measuring apparatus according to claim 3, wherein said irradiator (100) is placed such that the optical axis of the irradiation light is at an angle other than a vicinity of 45 degrees to the direction in which the blood flows.
- The measuring apparatus according to any of claims 1 to 4, whereinsaid irradiator (100) includes a first irradiator (110) and a second irradiator (120),said first light receiver (210) is configured to receive a forward scatter component of scattered light of the first irradiator (110);said second light receiver (220) is configured to receive a backscatter component of the scattered light of the first irradiator (110); andsaid third light receiver (230) is configured to receive a side scatter component of scattered light of the second irradiator (120).
- A measuring method comprising:an irradiating process of irradiating blood with light;a first light receiving process of receiving a forward scatter component of scattered light scattered by the blood;a second light receiving process of receiving a backscatter component of the scattered light;a third light receiving process of receiving a side scatter component of the scattered light; andan outputting process of outputting hematocrit value of the blood,characterised in that:the hematocrit value I is obtained on the basis of light receiving signals of said first light receiving process, said second light receiving process, and said third light receiving process,wherein said outputting process is configured to determine the hematocrit value using a relationship between the sum of the backscatter component and the side scatter component, and the forward scatter component.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2017/035678 WO2019064559A1 (en) | 2017-09-29 | 2017-09-29 | Measurement device, measurement method, computer program, and storage medium |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3690425A1 EP3690425A1 (en) | 2020-08-05 |
EP3690425A4 EP3690425A4 (en) | 2021-05-19 |
EP3690425B1 true EP3690425B1 (en) | 2023-07-19 |
Family
ID=65902502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17927545.8A Active EP3690425B1 (en) | 2017-09-29 | 2017-09-29 | Measurement device and measurement method for hematoctrit |
Country Status (4)
Country | Link |
---|---|
US (1) | US11209359B2 (en) |
EP (1) | EP3690425B1 (en) |
JP (1) | JP6858875B2 (en) |
WO (1) | WO2019064559A1 (en) |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2815435B2 (en) * | 1989-12-22 | 1998-10-27 | 株式会社日立製作所 | Particle analyzer and blood cell counter |
US5506679A (en) * | 1994-09-08 | 1996-04-09 | Hach Company | Nephelometer instrument |
JP3446410B2 (en) * | 1995-07-24 | 2003-09-16 | 株式会社島津製作所 | Laser diffraction particle size distribution analyzer |
JP3371816B2 (en) * | 1998-07-31 | 2003-01-27 | 株式会社島津製作所 | Particle concentration measuring method and device and particle measuring device |
SE9804142D0 (en) | 1998-11-30 | 1998-11-30 | Gambro Ab | Method and device for providing a signal |
US6519034B1 (en) * | 1998-12-16 | 2003-02-11 | Honeywell International Inc. | Oil quality sensor |
US6567166B2 (en) * | 2001-02-21 | 2003-05-20 | Honeywell International Inc. | Focused laser light turbidity sensor |
US6798508B2 (en) * | 2002-08-23 | 2004-09-28 | Coulter International Corp. | Fiber optic apparatus for detecting light scatter to differentiate blood cells and the like |
US6743634B2 (en) * | 2002-08-23 | 2004-06-01 | Coulter International Corp. | Method and apparatus for differentiating blood cells using back-scatter |
DE10330641A1 (en) * | 2003-07-07 | 2005-02-03 | Basf Coatings Ag | High-precision remission sensor for wet measurement of paints and pigment pastes |
WO2005116636A1 (en) * | 2004-05-25 | 2005-12-08 | Renner Herrmann S.A. | An apparatus and method for measuring the spectral properties of a fluid |
US7390662B2 (en) * | 2005-11-09 | 2008-06-24 | Beckman Coulter, Inc. | Method and apparatus for performing platelet measurement |
DE102006029899B4 (en) * | 2006-06-29 | 2009-06-04 | Fresenius Medical Care Deutschland Gmbh | Spectroscopic detector and method for the determination of blood and biological markers in liquids |
ES2796655T3 (en) * | 2008-11-14 | 2020-11-27 | Beckman Coulter Inc | Monolithic Optical Flow Cells and Manufacturing Method |
DE102009017304A1 (en) * | 2009-04-11 | 2010-10-21 | Fresenius Medical Care Deutschland Gmbh | Apparatus and method for measuring a blood component in blood for an extracorporeal blood treatment device |
US7973923B2 (en) * | 2009-04-27 | 2011-07-05 | Endress+Hauser Conducta Inc. | Multi-port inline flow cell for use in monitoring multiple parameters in a sanitary process line |
WO2013114333A1 (en) * | 2012-02-04 | 2013-08-08 | Centre For Cellular And Molecular Platforms (C-Camp) | Microfluidic flow analyzer for pathological detection and method thereof |
US9372143B2 (en) * | 2013-05-15 | 2016-06-21 | Captl Llc | Scanning image flow cytometer |
DE102013018284B4 (en) | 2013-10-31 | 2015-08-27 | Fresenius Medical Care Deutschland Gmbh | Method and device for detecting hemolysis or for determining a correction factor which corrects the influence of hemolysis on a measurement of the hematocrit |
KR20190045340A (en) * | 2016-09-13 | 2019-05-02 | 바스프 코팅스 게엠베하 | A sensor for measuring the permeation and / or forward scattering and / or re-emission substantially simultaneously and for simultaneously measuring the permeation and forward scattering or transmission and re-emission of the liquid sample |
IT201700073456A1 (en) * | 2017-06-30 | 2018-12-30 | Eos S R L | Method for characterization of objects by analysis of diffuse radiation and related instrumentation. |
-
2017
- 2017-09-29 US US16/651,563 patent/US11209359B2/en active Active
- 2017-09-29 JP JP2019544157A patent/JP6858875B2/en active Active
- 2017-09-29 WO PCT/JP2017/035678 patent/WO2019064559A1/en unknown
- 2017-09-29 EP EP17927545.8A patent/EP3690425B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
US11209359B2 (en) | 2021-12-28 |
JP6858875B2 (en) | 2021-04-14 |
WO2019064559A1 (en) | 2019-04-04 |
EP3690425A1 (en) | 2020-08-05 |
EP3690425A4 (en) | 2021-05-19 |
JPWO2019064559A1 (en) | 2020-10-15 |
US20200264100A1 (en) | 2020-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8054452B2 (en) | Spectroscopic detector and method for determining the presence of blood and biological marker substances in liquids | |
EP3001174B1 (en) | Blood analyzer and blood analyzing method | |
US6525807B1 (en) | Particle analyzing apparatus | |
EP1579196B1 (en) | Method and device for measurements in blood | |
EP3803330A1 (en) | Analysis apparatus and method for analyzing a viscosity of a fluid | |
EP3111211B1 (en) | Self calibrating blood chamber | |
JP6604611B2 (en) | Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method | |
CN208905860U (en) | Detection device for the medium in pipe section and the Medical Devices including it | |
CN105716680A (en) | Apparatus for determining a value that represents the amount of a liquid and its use | |
WO2005028001A1 (en) | An apparatus, a system and a method relating to hemodialysis, hemodiafiltration, hemofiltration or peritoneal dialysis | |
US9551659B2 (en) | Optical apparatus and method for fluorescence measurement of analytes comprising backscattering detection | |
EP3690425B1 (en) | Measurement device and measurement method for hematoctrit | |
ITMI20090926A1 (en) | SYSTEM AND METHOD FOR SPECTROPHOTOMETRIC MEASUREMENTS OF BLOOD PARAMETERS. | |
US20160271318A1 (en) | Method and apparatus for detecting hemolysis or for determining a correction factor to correct the influence of hemolysis on a measurement of hematocrit | |
WO1987003091A1 (en) | A method and apparatus for detecting the concentration of contaminants in a liquid | |
Schwarz et al. | Investigations on the capability of the statistical extinction method for the determination of mean particle sizes in concentrated particle systems | |
JP7175435B2 (en) | Flow velocity identification device | |
JP7285503B2 (en) | TOTAL PROTEIN MEASUREMENT DEVICE AND TOTAL PROTEIN MEASUREMENT METHOD | |
EP3017292A1 (en) | Method for determining the concentration of a substance in a deformable container | |
JP2016523373A5 (en) | ||
JP4793413B2 (en) | Differential refractive index detector | |
JP7344396B2 (en) | Water quality sensor and method for measuring substance concentration in water | |
CN118159829A (en) | Multi-wavelength ozone concentration sensor and use method thereof | |
Martínez et al. | Unclassified green dots on nucleated red blood cells (nRBC) plot in DxH900 from a patient with hyperviscosity syndrome | |
JPH05142236A (en) | Optical measuring apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200325 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602017071664 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: G01N0021490000 Ipc: G01N0021530000 Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: G01N0021490000 Ipc: G01N0021530000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210421 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 21/53 20060101AFI20210415BHEP Ipc: G01N 33/487 20060101ALI20210415BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NIKKISO COMPANY LIMITED Owner name: AIR WATER BIODESIGN INC. |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230214 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230414 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017071664 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20230719 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1589938 Country of ref document: AT Kind code of ref document: T Effective date: 20230719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231119 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231120 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231019 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231119 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231020 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017071664 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230929 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20230930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230929 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 |
|
26N | No opposition filed |
Effective date: 20240422 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: RPOT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230929 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240806 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240808 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240808 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20240812 Year of fee payment: 8 Ref country code: IT Payment date: 20240812 Year of fee payment: 8 |